The Hainan (Sanya) Marathon, held over the last weekend of 2025, marked the inaugural Class A-certified event sanctioned by the China Athletics Association (CAA) since the commencement of operations in the Hainan Free Trade Port (Hainan FTP) under its independent customs and trade regulations. Hainan FTP’s advantages in easier visa access, air connectivity, duty-free trade, […]
Wallonia Minister of Economy and Employment Pierre-Yves Jeholet will perform opening ceremony on 9 January 2026 New cleanroom facility allows production of one million doses per year Ramping up for clinical development in osteoarthritis in 2026 Supports launch of Synoglide(TM) in veterinary markets worldwide Liege, Belgium – 9 January 2026 (08:30 CET) – Allegro NV,
Allegro to start production of osteoarthritis hydrogel as it prepares for clinical trials GlobeNewswire January 09, 2026 Wallonia Minister of Economy and Employment Pierre-Yves Jeholet will perform opening ceremony on 9 January 2026 New cleanroom facility allows production of one million doses per year Ramping up for clinical development in osteoarthritis in 2026 Supports launch
Clinical study update Synartro is advancing the candidate drug SYN321, a novel intra-articular treatment for knee osteoarthritis, through a phase 1/2a clinical study focused on safety, tolerability, PK, and early efficacy signals. The study was initiated in August 2025 following approval from the Swedish Medical Products Agency (MPA) and the Swedish Ethical Review Authority. The
— Report to be released at approximately 7:00 AM CET on January 23, 2026 — One live video webcast for analysts, investors and journalists at 9:00 AM CET Ericsson's (NASDAQ: ERIC) financial report for the fourth quarter 2025 will be published at approximately 7:00 AM CET on January 23, 2026. The company will issue a
From March 18 to 31, 2026, the 57th China International Furniture Fair (CIFF Guangzhou 2026) will be held in Guangzhou under the theme CONNECT-CREATE. The Home Furniture Exhibition, as one of the three key exhibitions of CIFF Guangzhou, will take place from March 18 to 21. Spanning 430,000 square meters, it will allow overseas brands,
(TSX-V:PLSR),(OTC US:PSRHF),(Other OTC:PSRHF),(LSE – AIM:PLSR), THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR TO BE TRANSMITTED, DISTRIBUTED TO, OR SENT BY, ANY NATIONAL OR RESIDENT
(Copenhagen:ZEAL), Press release – No. 2 / 2026 Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy Access to Gefion, Denmark's flagship AI supercomputer, gives Zealand Pharma access to unprecedented computational power, enabling large-scale modeling, prediction, and optimization of drug candidates Agreement will
(Paris:TNG), TG4050 elicits strong polyepitopic, polyclonal, durable cytotoxic and effector neoantigen-specific CD8 T cell responses Results reinforce TG4050 potential as an individualized cancer immunotherapy Strasbourg, France, January 9, 2026, 8:00 a.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced the preprint
Pierre Fabre Laboratories and Iktos, a global leader in Artificial Intelligence (AI) and Robotics on drug discovery, today announced an integrated drug discovery collaboration to identify and develop novel small-molecule drug candidates in oncology. This initiative reflects both companies’ commitment to advancing oncology research by integrating complementary strengths across computational design, medicinal chemistry, biology, medical